P1.03-16 Anlotinib Inhibits Angiogenesis of Refractory Advanced Non-Small Cell Lung Cancer via Blocking CCL2 Expression

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.697
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?

Current Respiratory Care Reports
2013English

Neural-Cadherin Expression Associated With Angiogenesis in Non-Small-Cell Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2003English

P53 and Angiogenesis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Abietic Acid Suppresses Non-Small-Cell Lung Cancer Cell Growth via Blocking IKKβ/NF-κB Signaling

OncoTargets and Therapy
OncologyPharmacology
2019English

PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2016English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

P1.03-17 Functional Mechanism of GLDC Gene Alternative Splicing in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy